HBC(SH:603077) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-12-07 06:44Core Viewpoint - The company, Sichuan Hebang Biotechnology Co., Ltd., will hold an investor briefing on December 15, 2025, to discuss its Q3 2025 performance and financial results, allowing for interactive communication with investors [2][3]. Group 1: Meeting Details - The investor briefing is scheduled for December 15, 2025, from 15:00 to 16:00 [4]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [4]. - The format of the meeting will be an interactive online session [3][4]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [5]. - Questions can be submitted by investors from December 8 to December 12, 2025, through the Roadshow Center's website or via the company's email [5]. - The company will address commonly asked questions during the briefing [5]. Group 3: Attendees - Key attendees from the company include the actual controller and director, Mr. He Zhenggang; the chairman and general manager, Mr. Zeng Xiaoping; the director and CFO, Mr. Wang Jun; the board secretary, Ms. Jiang Siying; and the independent director, Ms. Song Ying [4]. Group 4: Contact Information - For inquiries, investors can contact the company's board office at phone number 028-62050230 or via email at jsy@hebang.cn [6][7].